Search

Author/Creator Gratt, Jeremy

1. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. Issue 9 (September 2016)

Authors:
Saad, Fred; Carles, Joan; Gillessen, Silke; Heidenreich, Axel; Heinrich, Daniel; Gratt, Jeremy; Lévy, Jérémy; Miller, Kurt; Nilsson, Sten; Petrenciuc, Oana; Tucci, Marcello; Wirth, Manfred; Federhofer, Judith; O'Sullivan, Joe M
Journal:
Lancet oncology
Issue:
Volume 17:Issue 9(2016:Sep.)
Page Start:
1306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. (28th November 2017)

Authors:
Sartor, Oliver; Vogelzang, Nicholas J.; Sweeney, Christopher; Fernandez, Daniel C.; Almeida, Fabio; Iagaru, Andrei; Brown, Alan; Smith, Matthew R.; Agrawal, Manish; Dicker, Adam P.; Garcia, Jorge A.; Lutzky, Jose; Wong, Yu‐Ning; Petrenciuc, Oana; Gratt, Jeremy; Shore, Neal D.; Morris, Michael J.
Journal:
Oncologist
Issue:
Volume 23:Number 2(2018)
Page Start:
193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search